Sanofi — SEC Form 4 filings

SEC reporting owner CIK 1121404. 2 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2026-08-07 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Attovia Therapeutics, Inc. (ATTO)10% owner11 leg · 300,000 sh · $5,100,0002
Latigo Biotherapeutics, Inc. (LTGO)10% owner14

Form 4 filings — Sanofi

FiledFormIssuerReported transactionsSource
2026-08-124Latigo Biotherapeutics, Inc. (LTGO)Conversion (C): 494,800 · Conversion (C): 177,978 · Conversion (C): 494,800 (derivative) · Conversion (C): 177,978 (derivative)EDGAR
2026-08-074Attovia Therapeutics, Inc. (ATTO)Conversion (C): 782,855 · Purchase (P): 300,000 @ $17 · Conversion (C): 782,855 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1121404 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →